Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic Cancer

NCT00267020 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Neoplasm

Interventions

DRUG: enzastaurin
DRUG: gemcitabine

Sponsor

Eli Lilly and Company